Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.

Anil Gupta,Yaneicy Gonzalez-Rojas,Erick Juárez,Manuel Crespo Casal,Jaynier Moya,Diego R. Falci,Elias Sarkis,Joel Solis,Hanzhe Zheng,Nicola Scott,Andrea L. Cathcart,Christy M. Hebner,Jennifer Sager,Erik Mogalian,Craig Tipple,Amanda Peppercorn,Elizabeth Alexander,Phillip S. Pang,Almena Free,Cynthia Brinson,Melissa Aldinger,Adrienne E Shapiro

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.

2021

Abstract Background Coronavirus disease 2019 (Covid-19) disproportionately results in hospitalization or death in older patients and those with underlying conditions. Sotrovimab is a pan-sarbecovir...

Keywords:

older patients
2019 20 coronavirus outbreak
Medicine
severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
Virology
Neutralizing antibody

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations